EXPERIMENTAL STUDY ON ISCHEMIA-REPERFUSION INJURY OF CIRRHOTIC LIVER -INFLUENCE OF GRADE OF HEPATIC CIRRHOSIS-
肝硬化缺血再灌注损伤的实验研究-肝硬化分级的影响-
基本信息
- 批准号:06671261
- 负责人:
- 金额:$ 1.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1.We studied the tolerance to ischemic injury of thioacetoamido-induced cirrhotic liver (TAA-liver) and normal liver. Rats underwent hepatic ischemia for 60 minutes. (1) One week survival in TAA-liver was significantly greater than that in normal liver. (2) Sixty minutes after the reperfusion, bile flow and recovery rate of bile flow in TAA-liver was significantly lower than those in normal liver. (3) Sixty minutes after the reperfusion, ATP concentration in TAA-liver was significantly lower than those in normal liver. (4) Sixty minutes after the reperfusion, TAN concentration in TAA-liver was significantly lower than those in normal liver. (5) Sixty minutes after the reperfusion, energy charge in TAA-liver was significantly lower than those in normal liver. These data suggested that tolerance to ischemic injury should be much lower in TAA-liver than those in normal liver.2.We compared the influence of continuous 60 minutes hapatic ischemia (group C) and intermittent hapatic ischemia (four times of 15 minutes of ischemia with five minutes intervals : group I) on TAA-liver in rats. (1) One week survival in group C was significantly greater than that in group I.(2) Sixty minutes after the reperfusion, bile flow and recovery rate of bile flow in group C was significantly lower than those in group I.(3) Sixty minutes after the reperfusion, ATP concentration in group C was significantly lower than those in group I.(4) Sixty minutes after the reperfusion, TAN concentration in group C was significantly lower than those in group I.(5) Sixty minutes after the reperfusion, energy charge in group C was significantly lower than those in group I.We might conclude that intermittent brief ischemia was useful when 60minutes of ischemia was required for the TAA-liver.
1.研究了硫代乙酰胺诱导的肝硬变(TAA-肝)和正常肝对缺血损伤的耐受性。大鼠肝脏缺血60min。(1)移植肝1周存活率显著高于正常肝。(2)再灌流60min后,TAA肝的胆汁流量和胆汁流量恢复率明显低于正常肝。(3)再灌流60min后,TAA肝组织中的ATP含量明显低于正常肝组织。(4)再灌流60min后,TAA肝组织中TAN含量明显低于正常肝组织。(5)再灌流60min后,TAA肝组织能荷显著低于正常肝组织。2.比较了连续60min肝缺血(C组)和间歇性肝缺血(I组)对大鼠TAA肝的影响。(2)再灌流60min后,C组胆汁流量及胆汁流量恢复率明显低于I组。(3)再灌流60min,C组三磷酸腺苷浓度明显低于I组。(4)再灌流60min,C组Tan浓度显著低于I组。C组的能荷显著低于I组。当TAA-肝脏需要缺血60min时,间歇性短暂缺血是有用的。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hirokazu Matsutomo, Hajime Hirose, Shoshi Senga, Hideo Itoh, Masatoshi Hayashi, Yoshihumi Katagiri, Tatsumi Iida, Masatomo Hayashi, Atsuyoshi Onitsuka: "An experimental stydy on tolerance to ischemic injury of thioacetamide-induced liver cirrhosis in rat"
Hirokazu Matsutomo、Hajime Hirose、Shoshi Senga、Hideo Itoh、Masatoshi Hayashi、Yoshihumi Katagiri、Tatsumi Iida、Masatomo Hayashi、Atsuyoshi Onitsuka:“大鼠硫代乙酰胺诱导的肝硬化缺血性损伤耐受性的实验研究”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
松友 寛和: "Thioacetamideによるラット硬変肝の虚血耐容能に関する実験的検討" 日本消化器外科学会雑誌掲載予定. 29. (1996)
松友博和:“硫代乙酰胺诱导的大鼠肝硬化缺血耐受性的实验研究”预定发表在日本胃肠外科学会杂志29号上。(1996年)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SENGA Shoshi其他文献
SENGA Shoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis
他汀类药物对肝硬化患者蛋白质组 HCC 风险特征的治疗调节
- 批准号:
10853142 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Elucidation of the Mechanism of Regenerative Insufficiency in Advanced Liver Cirrhosis Caused by Intestinal Bacterial Extracellular Vesicles and Development of Prevention and Treatment Methods
肠道细菌细胞外囊泡所致晚期肝硬化再生不足机制的阐明及防治方法的开发
- 批准号:
22H02866 - 财政年份:2022
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Liver Cirrhosis Network: Clinical Research Centers
肝硬化网络:临床研究中心
- 批准号:
10487561 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
肝硬化网络:临床研究中心 - 梅奥诊所
- 批准号:
10487453 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别:
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
肝硬化结果预防的策略和治疗:STOP-C 肝硬化网络
- 批准号:
10492742 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别:
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
肝硬化网络:纵向和临床试验研究
- 批准号:
10696089 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别:
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
肝硬化结果预防的策略和治疗:STOP-C 肝硬化网络
- 批准号:
10311423 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别:
Liver Cirrhosis Network: Clinical Research Centers
肝硬化网络:临床研究中心
- 批准号:
10700058 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别:
Liver Cirrhosis Network: Clinical Research Centers
肝硬化网络:临床研究中心
- 批准号:
10308126 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别:
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
肝硬化网络:纵向和临床试验研究
- 批准号:
10480915 - 财政年份:2021
- 资助金额:
$ 1.15万 - 项目类别: